IDH1 and central nervous system cancer: In 2016, the World Health Organisation (WHO) adopted isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) single nucleotide variants (SNVs) into its classification of gliomas [1].